Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

Read here for Financial analysis of Playstudios (MYPS), focusing on diversification strategy, cost-cutting, share buybacks, ...

We warn of overvalued Hanesbrands stock despite signs of recovery and advise holding with $5/share target. Read our ...

The bond vigilantes could move both stock and bond markets merely by pronouncing a view on where interest rates were headed.

We warn of challenges ahead for Accenture as ERP projects phase out and AI innovations threaten the consulting model. See why ...

Spire Global offers promising growth potential in AI and satellite data integration, making it a Buy despite recent financial ...

XP Inc. faces issues in Brazil's deteriorating macro environment, but demonstrates resilience with record net income and ...

Read here for highlights on LG Display's gains in 2024. It ended the year soft with disappointing Q4, casting doubt on its ...

Gladstone Investment, an Equity-oriented BDC, paid a special $0.70 per share dividend and has potential for valuation growth ...

NeurAxis has seen significant developments, including expanded FDA clearance, increased insurance coverage, and a new ...

Stock prices are high and concentrated which implies below average long term returns, while high starting yields are ...

Read here for an analysis on Humacyte (HUMA) stock post-Symvess approval, potential upside in revenue generation, and ...